HYCAMTIN (Novartis Pharmaceuticals Corporation)


Welcome to the PulseAid listing for the HYCAMTIN drug offered from Novartis Pharmaceuticals Corporation. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Novartis Pharmaceuticals Corporation
NON-PROPRIETARY NAME: topotecan
SUBSTANCE NAME: TOPOTECAN HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-07-07
END MARKETING DATE: 0000-00-00


HYCAMTIN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHYCAMTIN from Novartis Pharmaceuticals Corporation
LABELER NAME: Novartis Pharmaceuticals Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 0.25(mg/1)
START MARKETING DATE: 2017-07-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0078-0672_221854df-9a47-444a-98c8-2f77c370df1c
PRODUCT NDC: 0078-0672
APPLICATION NUMBER: NDA020981

Other TOPOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare, Inc.topotecan hydrochloride
Actavis Pharma, Inc.Topotecan hydrochloride
Bedford LaboratoriesTopotecan Hydrochloride
Fresenius Kabi USA, LLCTopotecan Hydrochloride
GlaxoSmithKline LLCHYCAMTIN
Hospira, Inc.Topotecan
Ingenus Pharmaceuticals, LLCTopotecan
Mylan Institutional LLCTOPOTECAN HYDROCHLORIDE
Novartis Pharmaceuticals CorporationHYCAMTIN
Pfizer Laboratories Div Pfizer Inc.Topotecan Hydrochloride
Sagent PharmaceuticalsTopotecan Hydrochloride
Sandoz IncTopotecan
Teva Parenteral Medicines, Inc.Topotecan
Three Rivers Pharmaceuticals, LLC.Topotecan Hydrochloride